Personalised Medicine

Michael Morrison is a Senior Researcher at the Centre for Health, Law and Emerging Technologies, University of Oxford. His work examines the social, ethical, and regulatory dimensions of biomedical innovation, focusing on regenerative medicine, personalised healthcare, and the governance of emerging biotechnologies.Saheli Datta Burton is a Lecturer in Science Policy at the Department of Science and Technology Studies (UCL-STS), University College London. Her work interrogates the political-economic and governance dimensions of emerging technologies, with a focus on the geostrategic shaping of data-driven health and biomedicine.Elisa Lievevrouw (PhD, KU Leuven) is a Postdoctoral Researcher at the Media Culture & Policy Lab, KU Leuven. She studies the interplay between innovation and policymaking in digital health and life sciences.Elisabetta Biasin is an Associate Researcher at the KU Leuven Centre for IT & IP Law. She studies the ethical and legal aspects of healthcare technologies, with a focus on medical device, AI, cybersecurity, and data laws.

• Series Editor Preface Foreword by Barbara Prainsack Chapter 1: Introduction: The Origins and Meaning of Personalised Medicine Chapter 2: The Perils and Promise of Data-Driven Medicine Chapter 3: Infrastructures and Infrastructur-ing Chapter 4: The Publics of Personalised Medicine Chapter 5: Personalisation in Treatment, Therapies, and Care Chapter 6: Health Data Governance in Personalised Medicine Chapter 7: The Possible Futures of Personalised Medicine References